EFFICACY OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST TUMOR-NECROSIS-FACTOR IN PROTECTING NEUTROPENIC RATS FROM LETHAL INFECTION WITH PSEUDOMONAS-AERUGINOSA

被引:93
作者
OPAL, SM
CROSS, AS
KELLY, NM
SADOFF, JC
BODMER, MW
PALARDY, JE
VICTOR, GH
机构
[1] BROWN UNIV,PROGRAM MED,PROVIDENCE,RI 02912
[2] WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,WASHINGTON,DC 20307
[3] CELLTECH LTD,SLOUGH,ENGLAND
关键词
D O I
10.1093/infdis/161.6.1148
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A monoclonal antibody directed against murine tumor necrosis factor- (TNF) was studied in a neutropenic rat model to determine its efficacy in protecting animals from lethal infection with Pseudomonas aeruginosa. Anti-TNF monoclonal antibody at a dose of 20 mg/kg given intravenously at 0 and 120 h resulted in a 53% survival rate (8/15) compared with no survival in control animals (0/15) (P <.(05). The combination of anti-TNF monoclonal antibody and oral ciprofloxacin at a suboptimal dose of 2.5 mg/kg/day resulted in a 100% survival rate in neutropenic animals (16/16), while ciprofloxacin alone produced only, a 67% survival rate (10/15) during the 7-day period of neutropenia (P <.05). Thus anti-TNF monoclonal antibody alone or in addition to antimicrobial agents improved survival in neutropenic animals after infection with P. oeruginosa. © 1990, University of Chicago. All rights reserved.
引用
收藏
页码:1148 / 1152
页数:5
相关论文
共 33 条